Published in J Neurochem on February 01, 2001
Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med (2006) 2.32
Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome. Blood (2009) 1.18
Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience (2006) 1.10
Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome. Biochim Biophys Acta (2011) 1.02
Tumorigenesis in Down's syndrome: big lessons from a small chromosome. Nat Rev Cancer (2012) 1.01
Impairment of circulating endothelial progenitors in Down syndrome. BMC Med Genomics (2010) 0.99
Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models. ACS Chem Neurosci (2013) 0.92
Superoxide dismutase 1 modulates expression of transferrin receptor. J Biol Inorg Chem (2006) 0.86
Redox processes in neurodegenerative disease involving reactive oxygen species. Curr Neuropharmacol (2012) 0.85
Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with trisomy 21. Oxid Med Cell Longev (2015) 0.77
Mice Overexpressing Both Non-Mutated Human SOD1 and Mutated SOD1(G93A) Genes: A Competent Experimental Model for Studying Iron Metabolism in Amyotrophic Lateral Sclerosis. Front Mol Neurosci (2016) 0.77
Cytochrome b5 reductase, a plasma membrane redox enzyme, protects neuronal cells against metabolic and oxidative stress through maintaining redox state and bioenergetics. Age (Dordr) (2015) 0.75
Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J (1984) 13.20
Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol (1990) 11.00
Mitochondrial complex I deficiency in Parkinson's disease. Lancet (1989) 5.72
Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J (1996) 5.14
The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med (1989) 5.10
Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys (1986) 4.67
Oxygen radicals and human disease. Ann Intern Med (1987) 4.57
Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature (1998) 4.34
Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem (1990) 4.03
Formation of thiobarbituric-acid-reactive substance from deoxyribose in the presence of iron salts: the role of superoxide and hydroxyl radicals. FEBS Lett (1981) 3.92
Glutathione and ascorbic acid in spinach (Spinacia oleracea) chloroplasts. The effect of hydrogen peroxide and of Paraquat. Biochem J (1983) 3.82
The presence of glutathione and glutathione reductase in chloroplasts: A proposed role in ascorbic acid metabolism. Planta (1976) 3.52
Superoxide-dependent formation of hydroxyl radicals in the presence of iron chelates: is it a mechanism for hydroxyl radical production in biochemical systems? FEBS Lett (1978) 3.14
The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci (1990) 2.86
Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine. Biochem J (1979) 2.82
The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med (1980) 2.81
The importance of free radicals and catalytic metal ions in human diseases. Mol Aspects Med (1985) 2.79
Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of 'free' iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem J (1981) 2.68
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol (1994) 2.65
Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet (1984) 2.53
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain (1991) 2.52
Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem (1997) 2.48
Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci (2000) 2.47
The importance of iron in rheumatoid disease. Lancet (1981) 2.44
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem (1989) 2.44
Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett (1994) 2.38
Intramitochondrial localisation of glycine decarboxylase in spinach leaves. Biochem Biophys Res Commun (1977) 2.34
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem (1989) 2.26
Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem (1997) 2.10
Subcellular localisation and identification of superoxide dismutase in the leaves of higher plants. Eur J Biochem (1978) 2.09
Relationship between plasma propranolol concentration and relief of essential tremor. J Neurol Neurosurg Psychiatry (1979) 2.04
Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat Rev Neurosci (2001) 2.04
Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med (1993) 1.95
Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem Toxicol (1994) 1.95
Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodents. Psychopharmacologia (1975) 1.93
Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Its role in degradation of hyaluronic acid by a superoxide-generating system. FEBS Lett (1978) 1.91
Inhibition of lipid peroxidation by the iron-binding protein lactoferrin. Biochem J (1981) 1.85
The chloroplast at work. A review of modern developments in our understanding of chloroplast metabolism. Prog Biophys Mol Biol (1978) 1.84
A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem (1997) 1.83
Superoxide-dependent formation of hydroxyl radicals: detection of hydroxyl radicals by the hydroxylation of aromatic compounds. Anal Biochem (1981) 1.82
Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J Biol Chem (1996) 1.78
The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett (1987) 1.77
Iron ion-dependent modification of bases in DNA by the superoxide radical-generating system hypoxanthine/xanthine oxidase. J Biol Chem (1989) 1.77
Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci Lett (2001) 1.73
Superoxide-dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Detection of 'catalytic' iron and anti-oxidant activity in extracellular fluids. Biochem J (1982) 1.72
Nitric oxide and oxygen radicals: a question of balance. FEBS Lett (1995) 1.70
Biochemical mechanisms accounting for the toxic action of oxygen on living organisms: the key role of superoxide dismutase. Cell Biol Int Rep (1978) 1.68
Copper-ion-dependent damage to the bases in DNA in the presence of hydrogen peroxide. Biochem J (1991) 1.68
Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Are lactoferrin and transferrin promoters of hydroxyl-radical generation? Biochem J (1987) 1.67
Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem (1990) 1.66
Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease? Exp Neurol (2005) 1.64
Oxidation of formate by peroxisomes and mitochondria from spinach leaves. Biochem J (1974) 1.62
Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci (Lond) (1984) 1.61
A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem (1989) 1.58
Oxidation of biologic molecules by ozone: the effect of pH. J Lab Clin Med (1993) 1.58
The role of superoxide and hydroxyl radicals in the degradation of hyaluronic acid induced by metal ions and by ascorbic acid. J Inorg Biochem (1981) 1.58
Production of superoxide, hydrogen peroxide and hydroxyl radicals by phagocytic cells: a cause of chronic inflammatory disease? Cell Biol Int Rep (1982) 1.57
Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. Neuroreport (1994) 1.56
Aldehyde-induced protein modifications in human plasma: protection by glutathione and dihydrolipoic acid. J Lab Clin Med (1994) 1.56
Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem (1989) 1.54
Effect of metoclopramide on turnover of brain dopamine noradrenaline and 5-hydroxytryptamine. J Pharm Pharmacol (1975) 1.54
Oxidants, antioxidants, and respiratory tract lining fluids. Environ Health Perspect (1994) 1.53
Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson's disease. Eur J Neurol (2012) 1.53
Acute dystonia induced by neuroleptic drugs. Psychopharmacology (Berl) (1986) 1.52
Effect of a specific iron chelating agent on animal models of inflammation. Ann Rheum Dis (1983) 1.52
Artifacts in cell culture: rapid generation of hydrogen peroxide on addition of (-)-epigallocatechin, (-)-epigallocatechin gallate, (+)-catechin, and quercetin to commonly used cell culture media. Biochem Biophys Res Commun (2000) 1.51
Methods for the measurement of hydroxyl radicals in biomedical systems: deoxyribose degradation and aromatic hydroxylation. Methods Biochem Anal (1988) 1.50
Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Identification of hydroxylated derivatives of salicylate in human body fluids. Biochem J (1986) 1.50
Alpha-tocopherol levels in brain are not altered in Parkinson's disease. Ann Neurol (1992) 1.49
Properties of freshly purified and thiol-treated spinach chloroplast fructose bisphosphatase. Biochem J (1980) 1.49
Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Is haemoglobin a biological Fenton reagent? Biochem J (1988) 1.49
Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise. Free Radic Biol Med (2001) 1.48
Protection against superoxide and hydrogen peroxide in synovial fluid from rheumatoid patients. Clin Sci (Lond) (1981) 1.48
Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts. Biochem J (2000) 1.48
The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects? Biochem Pharmacol (1987) 1.47
Micronutrients: oxidant/antioxidant status. Br J Nutr (2001) 1.47
Tyrosine modification by reactive nitrogen species: a closer look. Arch Biochem Biophys (1995) 1.45
Antioxidant and pro-oxidant properties of active rosemary constituents: carnosol and carnosic acid. Xenobiotica (1992) 1.44
Inhibitors of Cytochrome P-450s and their mechanism of action. Drug Metab Rev (1981) 1.42
Action of calcium ions on spinach (Spinacia oleracea) chloroplast fructose bisphosphatase and other enzymes of the Calvin cycle. Biochem J (1980) 1.41
Ascorbic acid, metal ions and the superoxide radical. Biochem J (1976) 1.40
Effect of hydrogen peroxide on spinach (Spinacia oleracea) chloroplast fructose bisphosphatase. Biochem J (1980) 1.39
Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction. Am J Clin Nutr (1995) 1.39
Increased nigral iron content in postmortem parkinsonian brain. Lancet (1987) 1.39
The in vitro cytotoxicity of ascorbate depends on the culture medium used to perform the assay and involves hydrogen peroxide. Antioxid Redox Signal (2001) 1.39
Oxidative decarboxylation of glycollate and glyoxylate by leaf peroxisomes. Biochem J (1974) 1.39
Measurement of allantoin and uric acid in human body fluids. A potential index of free-radical reactions in vivo? Biochem J (1987) 1.39
beta-Adrenoreceptor antagonists in essential tremor. J Neurol Neurosurg Psychiatry (1979) 1.39
Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem (1997) 1.38
Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochim Biophys Acta (1985) 1.37
An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J Neurochem (1997) 1.36
Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelates. J Biol Chem (1989) 1.35
Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res (1996) 1.35
Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett (1987) 1.34